Intravenous Immunoglobulin Therapy in Optic Neuritis

NCT00000117 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Optic Neuritis

Interventions

DRUG: Immunoglobulin

Sponsor

National Eye Institute (NEI)